John Bedford - Danaher Vice Relations

DHR Stock  USD 272.09  2.29  0.83%   

Executive

John Bedford is Vice Relations of Danaher
Address 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701
Phone202 828 0850
Webhttps://www.danaher.com

Danaher Management Efficiency

The company has Return on Asset of 0.0398 % which means that on every $100 spent on assets, it made $0.0398 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0798 %, implying that it generated $0.0798 on every 100 dollars invested. Danaher's management efficiency ratios could be used to measure how well Danaher manages its routine affairs as well as how well it operates its assets and liabilities. As of 10/22/2024, Return On Equity is likely to grow to 0.15, while Return On Tangible Assets are likely to drop 0.14. At this time, Danaher's Debt To Assets are relatively stable compared to the past year. As of 10/22/2024, Fixed Asset Turnover is likely to grow to 5.76, while Return On Tangible Assets are likely to drop 0.14.
Danaher has 19.54 B in debt with debt to equity (D/E) ratio of 0.43, which is OK given its current industry classification. Danaher has a current ratio of 1.74, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Danaher to invest in growth at high rates of return.

Similar Executives

Showing other executives

EXECUTIVE Age

Jakob WedelIllumina
N/A
Mark MintzCharles River Laboratories
N/A
Amy CianciarusoCharles River Laboratories
N/A
Bryan KippRevvity
N/A
Sallilyn SchwartzIllumina
N/A
Todd SpencerCharles River Laboratories
N/A
Ankur DhingraIllumina
48
Joel GoldbergRevvity
55
John HartIDEXX Laboratories
N/A
Stephen MurphyGuardant Health
N/A
John SaiaGuardant Health
51
Jonas GreutertMettler Toledo International
N/A
Pr FrearsonCharles River Laboratories
N/A
Magali FourRevvity
N/A
Sharon VidalIllumina
N/A
Marc GueronniereMettler Toledo International
60
Pat LeckmanIllumina
60
George FennellIDEXX Laboratories
55
Terilyn MonroeGuardant Health
57
Gerhard KellerMettler Toledo International
56
Christian MaglothMettler Toledo International
58
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Danaher Corp operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 78000 people. Danaher (DHR) is traded on New York Stock Exchange in USA. It is located in 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701 and employs 61,000 people. Danaher is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Danaher Leadership Team

Elected by the shareholders, the Danaher's board of directors comprises two types of representatives: Danaher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Danaher. The board's role is to monitor Danaher's management team and ensure that shareholders' interests are well served. Danaher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Danaher's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rainer Blair, President, Chief Executive Officer, Director
Angela Lalor, Senior Vice President - Human Resources
Pardis Sabeti, Independent Director
A Sanders, Independent Director
William King, Senior Vice President - Strategic Development
Matthew McGrew, Chief Financial Officer, Executive Vice President
Thomas Joyce, CEO and President Director and Member of Fin. Committee
Mitchell Rales, Chairman of the Executive Committee, Director
JoseCarlos GutierrezRamos, Senior Vice President Chief Scientific Officer
John Schwieters, Independent Director
Linda Filler, Lead Independent Director
Teri ListStoll, Independent Director
Daniel Raskas, Senior Vice President - Corporate Development
Daniel Comas, Executive Vice President
Elias Zerhouni, Independent Director
Brian Ellis, Senior Vice President, Chief Compliance Officer, General Counsel
Daniel JD, Senior Development
Raymond Stevens, Independent Director
Jessica Mega, Independent Director
Steven Rales, Chairman of the Board
John Bedford, Vice Relations
Alan Spoon, Independent Director
Robert Lutz, Senior Vice President Chief Accounting Officer
Walter Lohr, Independent Director
Christopher Bouda, Chief Accounting Officer, Vice President
Georgeann Couchara, Senior Vice President - Human Resources
Joakim Weidemanis, Executive Vice President
Jennifer Honeycutt, Executive Vice President

Danaher Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Danaher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Danaher

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Danaher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Danaher will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Danaher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Danaher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Danaher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Danaher to buy it.
The correlation of Danaher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Danaher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Danaher moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Danaher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Danaher Stock Analysis

When running Danaher's price analysis, check to measure Danaher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danaher is operating at the current time. Most of Danaher's value examination focuses on studying past and present price action to predict the probability of Danaher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danaher's price. Additionally, you may evaluate how the addition of Danaher to your portfolios can decrease your overall portfolio volatility.